ArticleESC heart failure2017
Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance.
Article in ESC heart failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Comment On: "Differential Outcomes of Beta-Blockers According to Heart Rate Following Myocardial Infarction with Reduced Left Ventricular Ejection Fraction".Cardiovascular drugs and therapy · 2026Article
- Atrial Fibrillation Modifies the Relationship Between Beta Blocker Dose and Physical Capacity After Myocardial Infarction.Clinics and practice · 2026Article
- Prognostic implication of outpatient loop diuretic dose intensification trajectories in patients with chronic heart failure.International journal of cardiology. Heart & vasculature · 2025Article
- Prognostic impact of outpatient loop diuretic reduction patterns in patients with chronic heart failure.International journal of cardiology. Heart & vasculature · 2024Article
- Efficacy and safety of digoxin in acute heart failure triggered by tachyarrhythmia.Journal of internal medicine · 2022Article
- Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study.BMC cardiovascular disorders · 2022Article
- Quantifying cardiac sympathetic denervation: first studies ofEuropean journal of nuclear medicine and molecular imaging · 2022Article
- Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis.Journal of the American Heart Association · 2021Article
- Different Impact of Beta-Blockers on Long-Term Mortality in Heart Failure Patients with and without Chronic Obstructive Pulmonary Disease.Journal of clinical medicine · 2021Article
- Lower In-Hospital Mortality With Beta-Blocker Use at Admission in Patients With Acute Decompensated Heart Failure.Journal of the American Heart Association · 2021Observational
- Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization.US cardiology · 2021Review
- Resting Oxygen Consumption and Heart Failure: Importance of Measurement for Determination of Cardiac Output With the Use of the Fick Principle.Journal of cardiac failure · 2020Article
- The difference in referencing in Web of Science, Scopus, and Google Scholar.ESC heart failure · 2019Article
- Open access efforts begin to bloom: ESC Heart Failure gets full attention and first impact factor.ESC heart failure · 2019Review
- Association between beta-adrenoceptor antagonist-induced sympathicolysis and severity of coronary artery disease as assessed by coronary computed tomography angiography (CCTA).The international journal of cardiovascular imaging · 2019Article
- Chronic vagal nerve stimulation exerts additional beneficial effects on the beta-blocker-treated failing heart.The journal of physiological sciences : JPS · 2019Article
- Exercise test is essential in LV-only fusion CRT pacing without right ventricle lead.Clinical interventions in aging · 2019Article
- Metabolic disorders in heart failure and cancer.ESC heart failure · 2018Review
- Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.ESC heart failure · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsExtent of cardiac sympathetic activation can be estimated from physiological parameters, blood biomarkers, and imaging findings. This study examined the prognostic value of three markers of sympathetic activity and their relationship to beta blocker dose in heart failure patients. METHODS AND
resultsA post hoc analysis of 858 heart failure subjects in the ADMIRE-HF trial was performed. Variables related to sympathetic activity were plasma norepinephrine, baseline heart rate, the heart to mediastinum (H/M) ratio of
conclusionsHigher beta blocker dose was associated with lower mortality, but of the variables associated with sympathetic activity examined, cardiac
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.